AROA BIOSURGERY LIMITED — Director's Dealing 2023

Mar 30, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	James McLean
Date of last notice	12 April 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest	N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change	31 March 2023
No. of securities held prior to change	Direct
	2,674,708 Fully Paid Ordinary Share
	102,400	Fully Paid Ordinary Share, to be
		held in escrow until 13 April 2023
	102,400	Options exercisable at $0.75
		expiring 23 July 2025
Class	Options exercisable at $1.083 expiring 29
	February	2028
Number acquired	258,929
Number disposed	-
Value/Consideration	Nil
Note: If consideration is non-cash, provide details and estimated
valuation

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Direct2,674,708 Fully Paid Ordinary Share102,400 Fully Paid Ordinary Share, to beheld in escrow until 13 April 2023102,400Options exercisable at $0.75expiring 23 July 2025258,929 Options exercisable at $1.083expiring 29 February 2028
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back	Issued on 31 March 2023 pursuant toshareholder approval received at the AnnualGeneral Meeting held on 10 August 2022

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder(if issued securities)	-
Date of change	-
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract inrelation to which the interest has changed	-
Interest acquired	-
Interest disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	-
Interest after change	-

Part 3 –[+] Closed period

Were the interests in the securities No or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance N/A provided to allow the trade to proceed during this period? If prior written clearance was N/A provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011